Aurinia Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary

Aurinia Pharmaceuticals

07/11/2024 14:39

* Aurinia Pharmaceuticals Inc  AUPH.OQ  reported quarterly
adjusted earnings of 10 cents​​ per share for the quarter ended
January 1, higher than the same quarter last year, when the
company reported EPS of -9 cents.  The mean expectation of
six analysts for the quarter was for earnings of 2 cents per
share. Wall Street expected results to range from -4 cents to 5
cents per share.
    * Revenue rose 24.3% to $67.77 million from a year ago;
analysts
expected $57.69 million. 
    * Aurinia Pharmaceuticals Inc's reported EPS for the quarter
was
10 cents​.
    * The company reported quarterly net income of $14.35
million.
    * Aurinia Pharmaceuticals Inc shares had risen by 2.6% this
quarter and lost 16.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aurinia
Pharmaceuticals Inc is 10.00 
This summary was machine generated from LSEG data November 7 at
02:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024                     0.10           
 Jun. 30 2024                     0.01           
 Mar. 31 2024      -0.14          -0.03          Beat
 Dec. 31 2023      -0.16          -0.19          Missed